SCHEMBL1609435

SCHEMBL1609435

COC(=O)c1nc(C2CC2)nc(N(C)Cc2ccc(Oc3ccccc3)cc2)c1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.45
PDE4D Q08499 2/20 0.45
CHRM3 P20309 1/20 0.45
PDE4A P27815 1/20 0.45
PDE4C Q08493 1/20 0.45
MMP13 P45452 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
PDE10A Q9Y233 1/20 0.38
KMT2A Q03164 2/20 0.37
DAGLA Q9Y4D2 1/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
LTA4H P09960 3/20 0.36
P2RX3 P56373 1/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12713104 0.92 PDE4B (0.43) PDE4BPDE4DCHRM3PDE4APDE4C
SCHEMBL1610429 0.90 PDE10A (0.41) PDE4BPDE4DCHRM3PDE4APDE4C
SCHEMBL1609979 0.88 PDE4B (0.42) PDE4BPDE4DCHRM3PDE4APDE4C
SCHEMBL1609421 0.87 PDE10A (0.43) PDE4BPDE4DCHRM3PDE4APDE4C
SCHEMBL1611545 0.86 PDE10A (0.41) PDE4BPDE4DCHRM3PDE4APDE4C
SCHEMBL1610476 0.86 PDE10A (0.41) PDE4BPDE4DCHRM3PDE4APDE4C
SCHEMBL1610294 0.86 PDE10A (0.41) PDE4BPDE4DCHRM3PDE4APDE4C
SCHEMBL1609728 0.85 PDE10A (0.42) PDE4BPDE4DCHRM3PDE4APDE4C
SCHEMBL1610220 0.85 MTNR1A (0.42) PDE4BPDE4DCHRM3PDE4APDE4C
Methane SCHEMBL1609436 0.84 TUBB4A (0.43) PDE4BPDE4DKMT2ACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110086759-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086759-A1 CHEMICAL COMPOUNDS DDT, PNPO, CBR3 PDE4B 1132/4885PDE4D 2126/4885CHRM3 2705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.